Bio Techne | TECH


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Agilent 116.26 0.59 0.51% -9.95%
Becton, Dickinson and Co. 248.11 6.35 2.63% -1.68%
Bio-Rad Laboratories 371.36 -1.99 -0.53% -32.79%
Bruker 70.94 1.84 2.66% 9.71%
Charles River Laboratories 196.34 2.96 1.53% -19.94%
Catalent 37.00 -0.23 -0.62% -66.57%
Danaher 232.69 3.07 1.34% -12.54%
Enzo Biochem 2.19 -0.01 -0.45% -15.44%
Exact Sciences 83.84 2.26 2.77% 63.69%
Standard Biotools 2.32 -0.03 -1.28% 16.58%
Hologic 79.15 0.26 0.33% 4.16%
Illumina 199.09 2.44 1.24% -19.89%
IQVIA Holdings 198.97 2.06 1.05% -9.58%
Merck 164.15 1.40 0.86% -6.09%
Mettler Toledo International 1,329.32 7.45 0.56% 0.23%
NanoString Technologies 5.73 -0.16 -2.72% -64.45%
OraSure Technologies 5.53 0.50 9.94% 34.22%
Pacific Biosciences Of California 12.86 0.48 3.88% 129.64%
PerkinElmer 115.67 0.35 0.30% -23.33%
Repligen 167.07 -0.85 -0.51% -3.07%
Bio Techne 81.69 -0.10 -0.12% -12.63%
Thermo Fisher Scientific 519.38 10.92 2.15% -6.94%
Waters 256.04 4.82 1.92% -23.12%

Indexes Price Day Year
USND 13101 165.70 1.28% 6.37%
US400 2426 19.58 0.81% -4.85%
US500 4230 41.19 0.99% 2.95%

Bio Techne

Bio Techne traded at $81.69 this Thursday June 1st, decreasing $0.10 or 0.12 percent since the previous trading session. Looking back, over the last four weeks, Bio Techne lost 1.86 percent. Over the last 12 months, its price fell by 12.63 percent. Looking ahead, we forecast Bio Techne to be priced at 81.10 by the end of this quarter and at 74.29 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.